Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma

Blood - Tập 101 Số 8 - Trang 2914-2923 - 2003
Laura Pasqualucci1, Anna Migliazza1,2, Katia Basso1,2, Jane Houldsworth1,2, R. S. K. Chaganti1,2, Riccardo Dalla‐Favera1,2
1From the Institute for Cancer Genetics and the Departments of Pathology and of Genetics and Development, Columbia University, New York; and the Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
2Institute for Cancer Genetics and the Departments of Pathology and of Genetics and Development, Columbia University, New York

Tóm tắt

Abstract The BCL6 proto-oncogene encodes a transcriptional repressor whose expression is deregulated by chromosomal translocations in approximately 40% of diffuse large B-cell lymphomas (DLBCLs). The BCL6 regulatory sequences are also targeted by somatic hypermutation in germinal center (GC) B cells and in a fraction of all GC-derived lymphomas. However, the functional consequences of these mutations are unknown. Here we report that a subset of mutations specifically associated with DLBCL causes deregulated BCL6 transcription. These mutations affect 2 adjacent BCL6 binding sites located within the first noncoding exon of the gene, and they prevent BCL6 from binding its own promoter, thereby disrupting its negative autoregulatory circuit. These alterations were found in approximately 16% of DLBCLs devoid of chromosomal translocations involving the BCL6 locus, but they were not found in normal GC B cells. This study establishes a novel mechanism for BCL6 deregulation and reveals a broader involvement of this gene in DLBCL pathogenesis.

Từ khóa


Tài liệu tham khảo

Ye, 1993, Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma., Science., 262, 747, 10.1126/science.8235596

Ye, 1993, Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma., Cancer Res., 53, 2732

Kerckaert, 1993, LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas., Nat Genet., 5, 66, 10.1038/ng0993-66

Baron, 1993, Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas., Proc Natl Acad Sci U S A., 90, 5262, 10.1073/pnas.90.11.5262

Onizuka, 1995, BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts., Blood., 86, 28, 10.1182/blood.V86.1.28.bloodjournal86128

Cattoretti, 1995, BCL-6 protein is expressed in germinal-center B cells., Blood., 86, 45, 10.1182/blood.V86.1.45.bloodjournal86145

Allman, 1996, BCL-6 expression during B-cell activation., Blood., 87, 5257, 10.1182/blood.V87.12.5257.bloodjournal87125257

Chang, 1996, BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor., Proc Natl Acad Sci U S A., 93, 6947, 10.1073/pnas.93.14.6947

Dent, 1997, Control of inflammation, cytokine expression, and germinal center formation by BCL-6., Science., 276, 589, 10.1126/science.276.5312.589

Ye, 1997, The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation., Nat Genet., 16, 161, 10.1038/ng0697-161

Seyfert, 1996, Transcriptional repression by the proto-oncogene BCL-6., Oncogene., 12, 2331

Harris, 1999, Transcriptional repression of Stat6-dependent interleukin-4–induced genes by BCL-6: specific regulation of epsilon transcription and immunoglobulin E switching., Mol Cell Biol., 19, 7264, 10.1128/MCB.19.10.7264

Shaffer, 2000, BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control., Immunity., 13, 199, 10.1016/S1074-7613(00)00020-0

Baron, 2002, The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis., Proc Natl Acad Sci U S A., 99, 2860, 10.1073/pnas.042702599

Fearon, 2001, Arrested differentiation, the self-renewing memory lymphocyte, and vaccination., Science., 293, 248, 10.1126/science.1062589

Niu, 1998, Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor., Genes Dev., 12, 1953, 10.1101/gad.12.13.1953

Bereshchenko, 2002, Acetylation inactivates the BCL6 transcriptional repressor., Nat Genet., 32, 606, 10.1038/ng1018

Lo Coco, 1994, Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma., Blood., 83, 1757, 10.1182/blood.V83.7.1757.1757

Butler, 2002, Alternative translocation breakpoint cluster region 5' to BCL6 in B-cell non-Hodgkin's lymphoma., Cancer Res., 62, 4089

Ye, 1995, Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma., EMBO J., 14, 6209, 10.1002/j.1460-2075.1995.tb00311.x

Chen, 1998, Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation., Blood., 91, 603, 10.1182/blood.V91.2.603

Shen, 1998, Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes., Science., 280, 1750, 10.1126/science.280.5370.1750

Pasqualucci, 1998, BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci., Proc Natl Acad Sci U S A., 95, 11816, 10.1073/pnas.95.20.11816

Peng, 1999, Nonimmunoglobulin gene hypermutation in germinal center B cells., Blood., 93, 2167, 10.1182/blood.V93.7.2167

Migliazza, 1995, Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma., Proc Natl Acad Sci U S A., 92, 12520, 10.1073/pnas.92.26.12520

Capello, 2000, Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia., Blood., 95, 651

Pasqualucci, 2000, BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia., Cancer Res., 60, 5644

Chang, 1995, Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators., Mol Cell Biol., 15, 5180, 10.1128/MCB.15.9.5180

Frank, 2001, Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation., Genes Dev., 15, 2069, 10.1101/gad.906601

Stuart, 1984, A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous gene., Proc Natl Acad Sci U S A., 81, 7318, 10.1073/pnas.81.23.7318

Kikuchi, 2000, Identification of negative regulatory regions within the first exon and intron of the BCL6 gene., Oncogene., 19, 4941, 10.1038/sj.onc.1203864

Becskei, 2000, Engineering stability in gene networks by autoregulation., Nature., 405, 590, 10.1038/35014651

Penn, 1990, Negative autoregulation of c-myc transcription., EMBO J., 9, 1113, 10.1002/j.1460-2075.1990.tb08217.x

Grignani, 1990, Negative autoregulation of c-myc gene expression is inactivated in transformed cells., EMBO J., 9, 3913, 10.1002/j.1460-2075.1990.tb07612.x

Nakamura, 1996, Internal DNA deletion within the BCL-6 gene on untranslocated chromosome in non-Hodgkin's lymphoma with 3q27 abnormality., Leukemia., 10, 658

Nakamura, 1999, Analysis of internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma., Br J Haematol., 105, 274

Bernardin, 1997, Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation., Oncogene., 14, 849, 10.1038/sj.onc.1200903

Bastard, 1994, LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients., Blood., 83, 2423, 10.1182/blood.V83.9.2423.2423

Vitolo, 1998, Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients., Ann Oncol., 9, 55, 10.1023/A:1008201729596

Barrans, 2002, Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma., Br J Haematol., 117, 322, 10.1046/j.1365-2141.2002.03435.x

Jerkeman, 2002, Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma: a Nordic Lymphoma Group study., Int J Oncol., 20, 161

Offit, 1994, Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma., N Engl J Med., 331, 74, 10.1056/NEJM199407143310202